Compare FHTX & VMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FHTX | VMD |
|---|---|---|
| Founded | 2015 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 323.4M | 369.2M |
| IPO Year | 2020 | 2018 |
| Metric | FHTX | VMD |
|---|---|---|
| Price | $4.18 | $10.72 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $11.50 | N/A |
| AVG Volume (30 Days) | 138.7K | ★ 212.8K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 25.32 | ★ 32.14 |
| EPS | N/A | ★ 0.06 |
| Revenue | $30,909,000.00 | ★ $270,280,000.00 |
| Revenue This Year | $8.89 | $17.88 |
| Revenue Next Year | $20.13 | $14.98 |
| P/E Ratio | ★ N/A | $177.33 |
| Revenue Growth | ★ 36.75 | 20.52 |
| 52 Week Low | $3.27 | $5.93 |
| 52 Week High | $6.95 | $10.68 |
| Indicator | FHTX | VMD |
|---|---|---|
| Relative Strength Index (RSI) | 52.37 | 68.48 |
| Support Level | $3.59 | $9.26 |
| Resistance Level | $4.64 | N/A |
| Average True Range (ATR) | 0.21 | 0.33 |
| MACD | 0.06 | 0.07 |
| Stochastic Oscillator | 85.33 | 91.28 |
Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.
Viemed Healthcare Inc is a provider of home medical equipment ("HME") and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women's health products and services. The Company's primary service offerings focus on effective in-home treatment, with clinical practitioners providing therapy and counseling to patients in their homes using cutting-edge technology. The company generates the majority of its revenue from medical equipment rental, sales, and supply.